These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36058508)

  • 41. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
    Mirza R; Sharma B
    Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of medium-chain fatty acid beta-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid.
    Bjorge SM; Baillie TA
    Biochem Biophys Res Commun; 1985 Oct; 132(1):245-52. PubMed ID: 3933498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes.
    Tong V; Teng XW; Chang TK; Abbott FS
    Toxicol Sci; 2005 Aug; 86(2):436-43. PubMed ID: 15858222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valproic acid and the liver.
    Cotariu D; Zaidman JL
    Clin Chem; 1988 May; 34(5):890-7. PubMed ID: 3131043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes.
    Jurima-Romet M; Abbott FS; Tang W; Huang HS; Whitehouse LW
    Toxicology; 1996 Aug; 112(1):69-85. PubMed ID: 8792850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyruvate uptake is inhibited by valproic acid and metabolites in mitochondrial membranes.
    Aires CC; Soveral G; Luís PB; ten Brink HJ; de Almeida IT; Duran M; Wanders RJ; Silva MF
    FEBS Lett; 2008 Oct; 582(23-24):3359-66. PubMed ID: 18775709
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
    Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
    Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of fatty acid metabolism in the hepatotoxicity induced by divalproex sodium.
    Wang W; Lin R; Zhang J; Mao Y; Bu X; Ji Q; Zhai X; Lin Q; Yang L; Zhang K
    Hum Exp Toxicol; 2012 Nov; 31(11):1092-101. PubMed ID: 22531971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between the perturbation of bile acid homeostasis and valproic acid-induced hepatotoxicity.
    Chen Y; Zhou J; Xu S; Liu M; Wang M; Ma Y; Zhao M; Wang Z; Guo Y; Zhao L
    Biochem Pharmacol; 2019 Dec; 170():113669. PubMed ID: 31628911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Valproate-associated hepatotoxicity--pathogenesis, clinical aspects, therapy and prevention].
    Siemes H; Nau H
    Klin Padiatr; 1991; 203(6):411-9. PubMed ID: 1758143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.
    Mandrekar P; Ambade A; Lim A; Szabo G; Catalano D
    Hepatology; 2011 Dec; 54(6):2185-97. PubMed ID: 21826694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis.
    Goda K; Saito K; Muta K; Kobayashi A; Saito Y; Sugai S
    J Toxicol Sci; 2018; 43(6):395-405. PubMed ID: 29877216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Valproate metabolism during valproate-associated hepatotoxicity in a surviving adult patient.
    McLaughlin DB; Eadie MJ; Parker-Scott SL; Addison RS; Henderson RD; Hooper WD; Dickinson RG
    Epilepsy Res; 2000 Oct; 41(3):259-68. PubMed ID: 10962217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions.
    Luder AS; Parks JK; Frerman F; Parker WD
    J Clin Invest; 1990 Nov; 86(5):1574-81. PubMed ID: 2243131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication.
    Löscher W; Nau H; Wahnschaffe U; Hönack D; Rundfeldt C; Wittfoht W; Bojic U
    Epilepsy Res; 1993 Jun; 15(2):113-31. PubMed ID: 8370349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme A metabolism by cotreatment with pantothenate and carnitine in developing mice: possible clinical significance.
    Thurston JH; Hauhart RE
    Pediatr Res; 1992 Apr; 31(4 Pt 1):419-23. PubMed ID: 1570210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gene expression profiles of murine fatty liver induced by the administration of valproic acid.
    Lee MH; Hong I; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
    Toxicol Appl Pharmacol; 2007 Apr; 220(1):45-59. PubMed ID: 17292431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance.
    Thurston JH; Carroll JE; Hauhart RE; Schiro JA
    Life Sci; 1985 Apr; 36(17):1643-51. PubMed ID: 3921791
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.
    Knapp AC; Todesco L; Beier K; Terracciano L; Sägesser H; Reichen J; Krähenbühl S
    J Pharmacol Exp Ther; 2008 Feb; 324(2):568-75. PubMed ID: 17986647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.